| Name | Title | Contact Details |
|---|
Unilife is a U.S-based medical device and technology company that designs, develops, manufactures and supplies innovative, differentiated delivery systems for injectable drugs, biologics and vaccines. Unilife has a broad portfolio of injectable drug delivery systems including prefilled syringes, auto-injectors, wearable injectors, drug reconstitution delivery systems, ocular delivery systems and novel devices. Unilife builds long-term partnerships with pharmaceutical and biotechnology companies seeking to leverage our products to enable, enhance and differentiate their injectable therapies. Unilife can develop or customize its device technologies to address the specific drug, commercial and patient needs of its pharmaceutical customers. Unilife’s dynamic business environment, advanced operational capabilities, world-class team and stringent quality processes enables the Company to serve the device innovation needs of its pharmaceutical customers with speed, agility and reliability. A state-of-the-art global headquarters and manufacturing facility in York, PA serves as an integrated center for the seamless design, development, production, quality control, regulatory compliance and commercial supply of its products.
Preferred Hearing Care is a Springfield, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
OCULO PLASTIK, INC is a Montrí©al, QC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Headquartered in Santa Barbara, California, Sientra offers leading transformative treatments and technologies focused on progressing the art of plastic surgery and making a difference in patients` lives. With unrivaled safety, state-of-the-art science and exceptional service; paired with unparalleled partnerships with plastic surgeons, the Sientra portfolio of proprietary innovations radically advances how plastic surgeons think, work and care for their patients. The company`s core breast products segment includes its state-of-the-art Sientra breast implants and its ground-breaking dual-port breast tissue expander, AlloX2® . In addition, the Sientra portfolio also includes BIOCORNEUM® the #1 performing, preferred and recommended scar gel of plastic surgeons(*) and miraDry, the only non-surgical, FDA-cleared device indicated for the permanent reduction of underarm sweat and hair and may also reduce odor.
Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign prostatic hyperplasia (BPH). Millions of patients do not see effective relief from drugs, yet decline to undergo an invasive surgical procedure with high risk of side effects such as sexual dysfunction.